Alfuzosin Hydrochloride contains not less than 99.0% and not more than 101.0% of C19H28ClN5O4, calculated on anhydrous substance.

共有 1 個藥物證書使用此成份

鹽酸阿夫唑辛
Alfuzosin Hydrochloride

• 申請商: 裕元興業股份有限公司
• 適應症: 良性前列腺肥大
• 發證日期: 2016-03-04